Gregory H Reaman

Gregory H Reaman

Auto-generated profile, based on publicly available information

Gregory H Reaman

National Cancer Institute , Bethesda, MD

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
JFJoseph Flores-Toro
Joseph Flores-Toro
SJSubhashini Jagu
Subhashini Jagu
MSMalcolm Smith
Malcolm Smith
JSJohn Shern
John Shern
DHDouglas S Hawkins
Douglas S Hawkins
GRGregory H Reaman
Gregory H Reaman
The Molecular Characterization Initiative (MCI), a key effort of the National Cancer Institute’s Childhood Cancer Data Initiative (CCDI), was launched in 2022 in collaboration with the Children’s Oncology Group (COG) to bring comprehensive genomic and molecular profiling to children, adolescents, and young adults diagnosed with cancer. The MCI provides paired tumor and germline molecular testing, with results returned to clinicians to inform care. Deidentified data are made available to the research community through the CCDI Data Ecosystem to facilitate the discovery of new treatment strategies. This commentary outlines the MCI’s development, key accomplishments to date, and its role in laying the foundation for standardized clinical diagnostics in pediatric oncology.